We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Kits Available for RNA Isolation from FFPET Samples and for cDNA Preamplification

By LabMedica International staff writers
Posted on 13 Nov 2012
A new kit will allow genomics researchers to isolate highly purified samples of RNA from FFPET (formalin-fixed, paraffin-embedded tissue) samples for analysis by microarray or for the generation of DNA for PCR studies.

The new High Pure FFPET RNA Isolation Kit was recently placed onto the biotech market by Roche (Basel, Switzerland). More...
This kit was designed for the isolation and purification of total RNA from 5 to 10 micrometer thick sections from FFPET. The isolated RNA is suitable for qRT-PCR (real-time PCR) and microarray analysis.

An investigator using the High Pure FFPET RNA Isolation Kit will require approximately 2.5 hours including the deparaffinization procedure to prepare an RNA sample. The deparaffinized tissue is lysed with special lysis buffers and incubated with Proteinase K. In the presence of chaotropic salts, the RNA is specifically bound to the glass fiber of the kit's High Pure Filter Tube. Bound RNA is then incubated with DNAse and purified in a series of rapid wash-and-spin steps and then eluted from the column. The RNA is recovered without contamination in an elution volume of 25-50 microliters.

The isolated RNA can be analyzed directly, or it may be transcribed into cDNA and subsequently preamplified with Roche's new RealTime Ready cDNA Pre-Amp Master Kit. This kit enables preamplification of minute amounts of cDNA with customized primer pools that correspond to primers that can be applied in subsequent qPCR analysis.

“Our new products provide highly convenient and flexible solutions to researchers who are analyzing gene expression in FFPET samples, while ensuring excellent result quality,” said Gerd Haberhausen, business head of qPCR and sample preparation systems at Roche. “By offering customized, aligned primer sets alongside our new RNA isolation kit, we are able to provide a complete and reliable workflow to scientists investigating the mRNA expression profiles of complex biological pathways.”

Related Links:

Roche



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.